X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com//news-release/2022/12/08/2569947/0/en/Clinigen-notes-results-from-the-MIROCALS-trial-investigating-low-dose-Proleukin-aldesleukin-in-patients-with-amyotrophic-lateral-sclerosis.html
https://ir.exelixis.com/news-releases/news-release-details/exelixis-announces-clinical-trial-collaboration-and-supply-0
https://www.biospace.com/article/releases/synthekine-launches-with-82-million-series-a-financing-to-advance-pipeline-of-engineered-cytokine-therapeutics-optimized-for-cancer-and-autoimmune-diseases/?s=80
https://www.clinigengroup.com/media/2010/clinigen_iovance_final-v2.pdf
https://www.biospace.com/article/clinigen-completes-acquisition-of-us-rights-to-proleukin/?s=79
https://www.reuters.com/article/us-clinigen-group-novartis/clinigen-buys-u-s-rights-to-novartis-cancer-drug-proleukin-idUSKCN1Q20O6
https://www.ema.europa.eu/documents/psusa-conclusions/aldesleukin-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable/00000076/201712_en.pdf
Market Place
Share 
